Literature DB >> 17127753

Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice.

Valeria Roca1, Luciana Larocca, Mario Calafat, Julieta Aisemberg, Roberto Meiss, Ana M Franchi, Claudia Pérez Leirós.   

Abstract

A functional interaction between progesterone, Th2 cytokines and a suitable balance between nitric oxide and prostaglandins in the uterus is considered to have a major role in the success of embryo implantation and pregnancy. Non-obese diabetic (NOD) mice offer a suitable model to study the modulatory role of Th1 cytokines on uterus signalling and function, since at the prediabetic stage they develop a spontaneous Th1 autoimmune response against exocrine glands similar to Sjögren's syndrome. Vasoactive intestinal peptide (VIP) is a vasoactive neuro- and immunopeptide that promotes Th2 profiles and contributes to the smooth muscle relaxation and vasodilation. The aim of the present study was to investigate the activities of nitric oxide synthase and cyclo-oxygenase and the effect of VIP in the uterus of NOD mice with an emerging Th1 cytokine response. We present evidence of a reduced basal and VIP-stimulated activity of both enzymes in the uterus of NOD mice compared with normal BALB/c mice in proestrus. An altered functional interaction between both enzymes is also present in NOD mice at the time when increased levels of serum interleukin (IL)-12 and tumour necrosis factor-alpha but not interferon (IFN)-gamma or IL-10 were detected. We conclude that signalling alterations in uteri of NOD mice are simultaneous to the onset of a systemic Th1 cytokine response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17127753     DOI: 10.1530/rep.1.01050

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  4 in total

1.  Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.

Authors:  V Hauk; M Calafat; L Larocca; L Fraccaroli; E Grasso; R Ramhorst; C Pérez Leirós
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

2.  VIP boosts regulatory T cell induction by trophoblast cells in an in vitro model of trophoblast-maternal leukocyte interaction.

Authors:  Laura Fraccaroli; Esteban Grasso; Vanesa Hauk; Daniel Paparini; Elizabeth Soczewski; Gil Mor; Claudia Pérez Leirós; Rosanna Ramhorst
Journal:  J Leukoc Biol       Date:  2015-04-15       Impact factor: 6.011

3.  Vasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands.

Authors:  Mario Calafat; Luciana Larocca; Valeria Roca; Vanesa Hauk; Nicolás Pregi; Alcira Nesse; Claudia Pérez Leirós
Journal:  Arthritis Res Ther       Date:  2009-04-08       Impact factor: 5.156

4.  VIP treatment prevents embryo resorption by modulating efferocytosis and activation profile of maternal macrophages in the CBAxDBA resorption prone model.

Authors:  Lucila Gallino; Guillermina Calo; Vanesa Hauk; Laura Fraccaroli; Esteban Grasso; Mónica Vermeulen; Claudia Pérez Leirós; Rosanna Ramhorst
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.